Search information pages
This page includes information about the aims and scope of GigaScience, editorial policies, open access and article-processing charges, the peer review process and other information. For details of how to prepare and submit a manuscript through the online submission system, please see the instructions for authors.
Aims & scope
GigaScience aims to revolutionize data dissemination, organization, understanding, and use. An online open-access open-data journal, we publish 'big-data' studies from the entire spectrum of life and biomedical sciences. To achieve our goals, the journal has a novel publication format: one that links standard manuscript publication with an extensive database that hosts all associated data and provides data analysis tools and cloud-computing resources.
Our scope covers not just 'omic' type data and the fields of high-throughput biology currently serviced by large public repositories, but also the growing range of more difficult-to-access data, such as imaging, neuroscience, ecology, cohort data, systems biology and other new types of large-scale sharable data.
GigaScience aims to increase transparency and reproducibility of research, emphasizing data quality and utility over subjective assessments of immediate impact. To enable future access and analyses, we require that all supporting data and source code be publically available and we provide an extensive database and cloud repository that can host associated data, supplementary information and tools.
A unique feature of our database is that important associated datasets can be given DOIs, providing both permanency and an additional citation. Thus GigaScience provides easier access to associated data as well as recognition for data producers.
GigaScience aims to help the growing number of studies that are based on extremely large data sets maximize their future access, analysis and re-use.
- Editor in Chief
- Laurie Goodman PhD
- Executive Editor
- Scott Edmunds PhD
- Commissioning Editor
- Nicole Nogoy PhD
- Lead Data Manager
- Peter Li PhD
- Lead Biocurator
- Chris Hunter PhD
- Database Developer
- Xiao Si Zhe
- Data Scientist
- Rob Davidson PhD
- Senior Journal Development Editor
- Sam Rose
All articles published by GigaScience are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.
Authors of articles published in GigaScience are the copyright holders of their articles and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate the article, according to the BioMed Central copyright and license agreement.
For authors who are US government employees or are prevented from being copyright holders for similar reasons, BioMed Central can accommodate non-standard copyright lines. Please contact us if further information is needed.
Open access publishing is not without costs. GigaScience therefore levies an article-processing charge of £1250/$1955/€1595 for each article accepted for publication. If the submitting author's institution is a Member, the cost of the article-processing charge is covered by the membership, and no further charge is payable. In the case of authors whose institutions are Supporter Members, however, a discounted article-processing charge is payable by the author. We routinely waive charges for authors from low-income countries. For other countries, article-processing charge waivers or discounts are granted on a case-by-case basis to authors with insufficient funds. Authors can request a waiver or discount during the submission process. For further details, see our article-processing charge page.
GigaScience is involved in a pilot study of new technology enabling the setting of article processing charges (APCs) at an article-type level within a journal instead of charging at a flat rate. APCs on this journal are as follows for the duration of the pilot:
|Article type||APC GBP||APC EUR||APC USD|
Payments from within the EU are subject to VAT. EU customers must supply their VAT Number to be exempt from VAT charge. UK Customers are not exempt from VAT charge
All articles published in GigaScience are included in:
- PubMed Central
The full text of all research articles published by BioMed Central is also available on SpringerLink.
BioMed Central is working closely with Thomson Reuters (ISI) to ensure that citation analysis of articles published in GigaScience will be available.
Publication and peer review process
Suitability of research for publication in GigaScience is dependent primarily on the data quality and utility, rather than a subjective assessment of immediate impact. To encourage transparent reporting of scientific research as well as enable future access and analyses, it is a requirement of submission that all supporting data and source code be made available.
Although GigaScience will not make general interest level the primary criterion for publication, it aims to provide its readership with the highest quality large-scale data research, and will therefore focus on usability and utility for the community.
All submitted research papers are subject to immediate rapid screening by the editors, in consultation with the Editorial Board if appropriate, to ensure they fall within the scope of the journal. Contributors who are in doubt about the suitability of their paper are welcome to send a presubmission enquiry. The editors will provide an initial response to all presubmission enquiries and submitted articles within five working days.
Manuscripts will be reviewed by internationally recognized experts selected in part from our Data Reviewer and Editorial Board. To further increase transparency, GigaScience promotes open (non-anonymous) peer-review. As a default, we will pass a reviewer's name on to the authors along with the comments. However, if reviewers do not wish to have their name revealed, we will honor that request. Reviewers are also asked to declare any competing interests and have to agree to open peer review, which works on two levels: the authors receive the signed report and, if the manuscript is published, the same report is available to the readers. The pre-publication history (initial submission, reviews and revisions - see, for example, pre-publication history) is posted on the web with the published article. Reviews will be rapid and the suitability of a paper for publication will be assessed primarily on criteria of scientific excellence and rigor. The editors will make every effort to give authors a decision following peer review within four weeks of an article's submission. Articles are published electronically as promptly as possible after they are accepted, and within one month of acceptance.
Technical Note : Software articles describing in detail the capabilities of a new or improved cloud-based computational tool for the analysis of large-scale datasets or the application of an existing computational tool in a new way to a research problem. It is a requirement of submission that the tool be deposited in the BGI cloud and be made available under an open-source license, and that the code described be documented and tested to high standards.
Review/Commentary : Having a focus on any large-scale data producing research in all of Biology means GigaScience is a perfect forum for the publication of papers that set the standards in any emerging field of high-throughput Biology. Reviews and Commentary on issues relating to data re-use, reproducibility and standardization will be given special consideration.
GigaScience operates using an open peer review system, where the reviewers' names are included on the peer review reports. In addition, if the article is published, the named reports are published online alongside the article as part of a 'pre-publication history'. All previous versions of the manuscript, and all author responses to the reviewers are also available to readers.
Authors will be able to check the progress of their manuscript through the submission system at any time by logging into My GigaScience, a personalized section of the site.
Copyediting and proofs
GigaScience will copyedit manuscripts before they are published.
Following the acceptance of an article, it is published in GigaScience as a provisional PDF file with minimal delay (subject to formatting checks, copyediting and author verification). Fully formatted PDF and full-text (HTML) versions are made available shortly after that.
High-quality, bound reprints can be purchased for all articles published. Please see our reprints website for further information about ordering reprints.
GigaScience will consider supplements based on proceedings (full articles or meeting abstracts), reviews or research. All articles submitted for publication in supplements are subject to peer review. Published supplements are fully searchable and freely accessible online and can also be produced in print. For further information, please contact us.
All manuscripts submitted to GigaScience should adhere to BioMed Central's editorial policies.
Minimum standards for reporting checklist
GigaScience advocates full and transparent reporting. For all articles reporting original research, excluding commentaries, reviews, and the like, please ensure that your paper provides the information detailed in our Minimum Standards for Reporting Checklist. On submitting your article you will be asked to confirm you have included this information, or give reasons for any instances where it is not made available or not applicable.
Citing articles in GigaScience
Articles in GigaScience should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number.
Article citations follow this format:
Authors: Title. Giga Sci [year], [volume number]:[article number].
e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. Giga Sci 2009, 1:115.
refers to article 115 from Volume 1 of the journal.
Why publish your article in GigaScience?
GigaScience's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience. Articles that have been especially highly accessed are highlighted with a 'Highly accessed' graphic, which appears on the journal's contents pages and search results.
Speed of publication
GigaScience offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both fully browsable web form, and as a formatted PDF; the article will then be available through GigaScience and BioMed Central.
Online publication in GigaScience gives authors the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles).
Promotion and press coverage
Articles published in GigaScience are included in article alerts and regular email updates. Some may be included in abstract books mailed to academics and are highlighted on GigaScience's pages and on the BioMed Central homepage.
In addition, articles published in GigaScience may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in GigaScience. A list of articles recently press-released by journals published by BioMed Central is available here.
Authors of articles published in GigaScience retain the copyright of their articles and are free to reproduce and disseminate their work (for further details, see the BioMed Central copyright policy and license agreement).
For further information about the advantages of publishing in a journal from BioMed Central, please click here.